Recursion Pharmaceuticals, Inc. RXRX
3.74
(0.15)
(3.86%)
as of 25 Sep
- Market cap
- $2.1B
- P/E
- 0.0×
Follow RXRX
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(91.06%) | (59.54%) | (57.16%) | (56.58%) | |
| (67.31%) | (44.12%) | (42.33%) | (41.26%) | ||
ROIC |
(114.23%) | (103.19%) | (98.34%) | (92.22%) | |
Return on Tangible Assets |
(106.68%) | (83.84%) | (82.85%) | (90.52%) | |
Average Days of Receivables |
183.05 | 120.47 | 74.67 | 95.77 | |
Free Cash Flow per Share |
(1.01) | (0.85) | (0.62) | (0.67) | |
Free Cash Flow |
(450.20) | (380.43) | (328.08) | (354.26) | |
Capital Expenditures |
(9.03) | (8.63) | (7.13) | (3.78) | |
Piotroski F-Score |
3.00 | 3.00 | 5.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
(25.62%) | (19.69%) | (18.97%) | (23.83%) | |
Accounts Receivable Turnover |
3.62 | 2.02 | 2.22 | 3.05 | |
Accounts Payable Turnover |
8.58 | 3.57 | 2.71 | 3.31 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
73.21 | 93.20 | 120.54 | 87.36 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | (0.01) | (0.01) | |
Research and Development Expense of Revenue |
1,093.33% | 636.40% | 652.83% | 719.19% | |
Selling, General and Administrative Expense of Revenue |
503.83% | 236.46% | 235.71% | 276.02% | |
Share Based Compensation of Revenue |
270.65% | 148.93% | 146.64% | 165.38% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.62 | 0.58 | 0.57 | 0.68 | |
Depreciation/Fixed assets |
0.69 | 0.81 | 0.88 | 0.87 | |
Capex/Depreciation |
(0.12) | (0.10) | (0.08) | (0.05) | |
Revenue per Share |
0.10 | 0.17 | 0.13 | 0.10 | |
Operating CF per Share |
(0.99) | (0.83) | (0.61) | (0.66) | |
Capex per Share |
(0.02) | (0.02) | (0.01) | (0.01) | |
Capex to Sales |
0.21 | 0.12 | 0.11 | 0.07 | |
Net Profit Margin |
(1,637.81%) | (863.35%) | (842.93%) | (945.92%) |
Columns are period end dates